LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | GSK1059615 | 1.11 | uM | LJP5 | 1 | E03 | 72 | hr | 658 | 1474 | 3908 | 0.3771 | 0.3685 |
Hs 578T | GSK1059615 | 1.11 | uM | LJP5 | 2 | E03 | 72 | hr | 658 | 1480 | 3953 | 0.3743 | 0.3679 |
Hs 578T | GSK1059615 | 1.11 | uM | LJP5 | 3 | E03 | 72 | hr | 658 | 1616 | 3938 | 0.4103 | 0.4162 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 658 | 815 | 3705 | 0.2199 | 0.0895 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 658 | 884 | 3807 | 0.2322 | 0.1235 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 658 | 882 | 3769 | 0.2340 | 0.1233 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 658 | 692 | 3908 | 0.1771 | 0.0197 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 658 | 808 | 3953 | 0.2044 | 0.0825 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 658 | 723 | 3938 | 0.1836 | 0.0371 |
Hs 578T | GSK1059615 | 10 | uM | LJP6 | 1 | C01 | 72 | hr | 658 | 511 | 3705 | 0.1379 | -0.0965 |
Hs 578T | GSK1059615 | 10 | uM | LJP6 | 2 | C01 | 72 | hr | 658 | 377 | 3807 | 0.0990 | -0.1975 |
Hs 578T | GSK1059615 | 10 | uM | LJP6 | 3 | C01 | 72 | hr | 658 | 550 | 3769 | 0.1459 | -0.0688 |
Hs 578T | GSK1059615 | 10 | uM | LJP5 | 1 | E01 | 72 | hr | 658 | 243 | 3908 | 0.0622 | -0.3214 |
Hs 578T | GSK1059615 | 10 | uM | LJP5 | 2 | E01 | 72 | hr | 658 | 205 | 3953 | 0.0519 | -0.3630 |
Hs 578T | GSK1059615 | 10 | uM | LJP5 | 3 | E01 | 72 | hr | 658 | 222 | 3938 | 0.0564 | -0.3437 |
Hs 578T | Brivanib | 0.04 | uM | LJP5 | 1 | P18 | 72 | hr | 658 | 3718 | 3908 | 0.9513 | 0.9615 |
Hs 578T | Brivanib | 0.04 | uM | LJP5 | 2 | P18 | 72 | hr | 658 | 3827 | 3953 | 0.9680 | 0.9750 |
Hs 578T | Brivanib | 0.04 | uM | LJP5 | 3 | P18 | 72 | hr | 658 | 3852 | 3938 | 0.9781 | 0.9829 |
Hs 578T | Brivanib | 0.12 | uM | LJP5 | 1 | P17 | 72 | hr | 658 | 3676 | 3908 | 0.9405 | 0.9528 |
Hs 578T | Brivanib | 0.12 | uM | LJP5 | 2 | P17 | 72 | hr | 658 | 3508 | 3953 | 0.8873 | 0.9096 |
Hs 578T | Brivanib | 0.12 | uM | LJP5 | 3 | P17 | 72 | hr | 658 | 3693 | 3938 | 0.9377 | 0.9508 |
Hs 578T | Brivanib | 0.37 | uM | LJP5 | 1 | P16 | 72 | hr | 658 | 3884 | 3908 | 0.9937 | 0.9951 |
Hs 578T | Brivanib | 0.37 | uM | LJP5 | 2 | P16 | 72 | hr | 658 | 3544 | 3953 | 0.8964 | 0.9172 |
Hs 578T | Brivanib | 0.37 | uM | LJP5 | 3 | P16 | 72 | hr | 658 | 3780 | 3938 | 0.9598 | 0.9684 |
Hs 578T | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 658 | 3593 | 3908 | 0.9193 | 0.9356 |